05/29/2026
𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐝𝐨𝐞𝐬𝐧’𝐭 𝐧𝐞𝐞𝐝 𝐦𝐨𝐫𝐞 𝐭𝐞𝐜𝐡. 𝐈𝐭 𝐧𝐞𝐞𝐝𝐬 𝐛𝐞𝐭𝐭𝐞𝐫 𝐭𝐞𝐜𝐡 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐲.
Today, many sites are managing an overwhelming mix of sponsor portals, spreadsheets, disconnected systems, and manual processes, often across dozens of technologies per study.
The result? More duplicate work, operational drag, staff fatigue, and slower study ex*****on.
That’s why the conversation around 𝐁𝐫𝐢𝐧𝐠 𝐘𝐨𝐮𝐫 𝐎𝐰𝐧 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 (𝐁𝐘𝐎𝐓) matters.
The BYOT Playbook, championed by DTRA and co-authored by RealTime's own Rick Greenfield alongside leaders from GSK, Eli Lilly, BMS, Medidata, Mayo Clinic, and more, outlines a practical framework for allowing sites to use their validated technologies — including eSource, eReg/eISF, and eConsent — within sponsor-funded clinical trials.
Rather than forcing sites to adopt new sponsor-mandated tools for every study, BYOT enables sites to leverage validated systems they already know and trust, without compromising sponsor oversight, compliance, and data quality.
When sites can work in familiar systems, they:
✔ spend less time training on new platforms.
✔ reduce duplicate work and manual handoffs.
✔ simplify day-to-day trial ex*****on + reduce staff burden.
✔ improve consistency across studies, staff, and processes.
✔ create more capacity for participants and studies.
For sites, it means reclaiming efficiency and autonomy.
For sponsors, it means accelerating trials without sacrificing oversight.
For participants, it means better experiences and faster access to care.
As interoperability standards like CDISC ODM, USDM, and FHIR continue to mature, the industry has an opportunity to move toward technology alignment.
What if the answer isn't more technology, but trusting the technology sites already use?
🔗 Read the full breakdown here: https://realtime-eclinical.com/2025/10/13/bring-your-own-technology-byot-the-future-of-site-led-technology-in-clinical-trials/
